Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 1.78 | 1.68 |
NAV | ₹32.47 | ₹207.80 |
Fund Started | 11 Feb 2015 | 20 Aug 2004 |
Fund Size | ₹6054.10 Cr | ₹15687.54 Cr |
Exit Load | Exit load of 0.5%, if redeemed within 90 days. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 4.29% | 13.24% |
3 Year | 7.97% | 22.17% |
5 Year | 17.57% | 22.49% |
1 Year
3 Year
5 Year
Equity | 97.70% | 83.94% |
Cash | -0.07% | 15.74% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 8.07% |
ICICI Bank Ltd. | 7.81% |
Reliance Industries Ltd. | 5.14% |
Tata Consultancy Services Ltd. | 4.80% |
Persistent Systems Ltd. | 3.50% |
Varun Beverages Ltd. | 3.12% |
Bharti Airtel Ltd. | 2.81% |
Multi Commodity Exchange Of India Ltd. | 2.49% |
Dixon Technologies (India) Ltd. | 2.34% |
Sun Pharmaceutical Industries Ltd. | 2.26% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.18% |
HDFC Bank Ltd. | 8.88% |
Axis Bank Ltd. | 8.49% |
Maruti Suzuki India Ltd. | 4.90% |
SBI Life Insurance Company Ltd. | 4.26% |
Kotak Mahindra Bank Ltd. | 4.24% |
Cipla Ltd. | 3.96% |
Bharti Airtel Ltd. | 3.63% |
HCL Technologies Ltd. | 3.41% |
Piramal Pharma Ltd. | 3.12% |
Name | Vivek Sharma | Dhruv Muchhal |
Start Date | 15 Feb 2025 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate income & capital appreciation by predominantly investing in an actively managed diversified portfolio of equity & equity related instruments including derivatives. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 11 Feb 2015 | 20 Aug 2004 |
Description
Launch Date